论文信息 - Proteomic patterns in serum and identification of ovarian cancer - 字舞流文

Proteomic patterns in serum and identification of ovarian cancer

[1] T. Bourne,et al. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. , 1993, BMJ.

[2] R. Bast,et al. Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers , 1995, Cancer.

[3] G J Whitman,et al. Positive predictive value of breast biopsy performed as a result of mammography: there is no abrupt change at age 50 years. , 1996, Radiology.

[4] Steven J Skates,et al. Screening for ovarian cancer: a pilot randomised controlled trial , 1999, The Lancet.

[5] R. Berkowitz,et al. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. , 2001, Journal of the National Cancer Institute.

[6] Elise C. Kohn,et al. The microenvironment of the tumour–host interface , 2001, Nature.

[7] E. Petricoin,et al. Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.

[8] R. Ozols,et al. The search for predictive patterns in ovarian cancer: proteomics meets bioinformatics. , 2002, Cancer cell.

[9] G. Mills,et al. Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. , 2002, Cancer treatment and research.

[10] R. Berkowitz,et al. Osteopontin as a potential diagnostic biomarker for ovarian cancer. , 2002, JAMA.

[11] S. Mcphee,et al. Current Medical Diagnosis and Treatment , 2009, Journal of Nuclear Medicine.